Results 161 to 170 of about 18,139 (185)

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2010
Frank L Greenway, Eduardo Dunayevich
exaly  

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

Lancet, The, 2011
Evgeny M Krupitsky, Edward V Nunes, Bernard L Silverman   +2 more
exaly  

Naltrexone

Reactions Weekly, 2019
openaire   +1 more source

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2008
Marek C Chawarski
exaly  

Naltrexone

Reactions Weekly, 2016
openaire   +2 more sources

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

New England Journal of Medicine, 2016
Joshua D Lee, Peter D Friedmann, Edward V Nunes   +2 more
exaly  

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Obesity, 2013
Caroline M Apovian, Louis J Aronne, Domenica M Rubino   +2 more
exaly  

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial

Obesity, 2011
Thomas A Wadden, Patrick M O'neil, Michael G Perri   +2 more
exaly  

Naltrexone

Reactions Weekly, 2002
openaire   +1 more source

Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss

Pharmacological Research, 2014
Puspha Sinnayah, Michael A Cowley
exaly